Johnson & Johnson Total Assets 1986-2025 | JNJ
Johnson & Johnson total assets from 1986 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Johnson & Johnson total assets for the quarter ending June 30, 2025 were $193.389B, a 6.79% increase year-over-year.
- Johnson & Johnson total assets for 2024 were $180.104B, a 7.49% increase from 2023.
- Johnson & Johnson total assets for 2023 were $167.558B, a 10.58% decline from 2022.
- Johnson & Johnson total assets for 2022 were $187.378B, a 2.94% increase from 2021.
Johnson & Johnson Annual Total Assets
(Millions of US $) |
| 2024 |
$180,104 |
| 2023 |
$167,558 |
| 2022 |
$187,378 |
| 2021 |
$182,018 |
| 2020 |
$174,894 |
| 2019 |
$157,728 |
| 2018 |
$152,954 |
| 2017 |
$157,303 |
| 2016 |
$141,208 |
| 2015 |
$133,411 |
| 2014 |
$130,358 |
| 2013 |
$132,683 |
| 2012 |
$121,347 |
| 2011 |
$113,644 |
| 2010 |
$102,908 |
| 2009 |
$94,682 |
| 2008 |
$84,912 |
| 2007 |
$80,954 |
| 2006 |
$70,556 |
| 2005 |
$58,864 |
| 2004 |
$53,317 |
| 2003 |
$48,263 |
| 2002 |
$40,556 |
| 2001 |
$38,488 |
| 2000 |
$34,245 |
| 1999 |
$29,163 |
| 1998 |
$26,211 |
| 1997 |
$21,453 |
| 1996 |
$20,010 |
| 1995 |
$17,873 |
| 1994 |
$15,668 |
| 1993 |
$12,242 |
| 1992 |
$11,884 |
| 1991 |
$10,513 |
| 1990 |
$9,506 |
| 1989 |
$7,919 |
| 1988 |
$7,119 |
| 1987 |
$6,546 |
| 1986 |
$5,877 |
| 1985 |
$5,095 |
Johnson & Johnson Quarterly Total Assets
(Millions of US $) |
| 2025-06-30 |
$193,389 |
| 2025-03-31 |
$193,671 |
| 2024-12-31 |
$180,104 |
| 2024-09-30 |
$178,287 |
| 2024-06-30 |
$181,088 |
| 2024-03-31 |
$171,966 |
| 2023-12-31 |
$167,558 |
| 2023-09-30 |
$166,061 |
| 2023-06-30 |
$191,686 |
| 2023-03-31 |
$195,969 |
| 2022-12-31 |
$187,378 |
| 2022-09-30 |
$175,124 |
| 2022-06-30 |
$177,724 |
| 2022-03-31 |
$178,355 |
| 2021-12-31 |
$182,018 |
| 2021-09-30 |
$179,228 |
| 2021-06-30 |
$176,440 |
| 2021-03-31 |
$172,557 |
| 2020-12-31 |
$174,894 |
| 2020-09-30 |
$170,693 |
| 2020-06-30 |
$158,380 |
| 2020-03-31 |
$155,017 |
| 2019-12-31 |
$157,728 |
| 2019-09-30 |
$155,521 |
| 2019-06-30 |
$155,117 |
| 2019-03-31 |
$150,027 |
| 2018-12-31 |
$152,954 |
| 2018-09-30 |
$155,703 |
| 2018-06-30 |
$155,365 |
| 2018-03-31 |
$156,625 |
| 2017-12-31 |
$157,303 |
| 2017-09-30 |
$155,658 |
| 2017-06-30 |
$152,807 |
| 2017-03-31 |
$144,918 |
| 2016-12-31 |
$141,208 |
| 2016-09-30 |
$140,369 |
| 2016-06-30 |
$139,814 |
| 2016-03-31 |
$136,231 |
| 2015-12-31 |
$133,411 |
| 2015-09-30 |
$133,266 |
| 2015-06-30 |
$132,036 |
| 2015-03-31 |
$128,590 |
| 2014-12-31 |
$130,358 |
| 2014-09-30 |
$132,097 |
| 2014-06-30 |
$135,200 |
| 2014-03-31 |
$133,330 |
| 2013-12-31 |
$132,683 |
| 2013-09-30 |
$126,933 |
| 2013-06-30 |
$124,325 |
| 2013-03-31 |
$121,536 |
| 2012-12-31 |
$121,347 |
| 2012-09-30 |
$118,951 |
| 2012-06-30 |
$115,750 |
| 2012-03-31 |
$116,194 |
| 2011-12-31 |
$113,644 |
| 2011-09-30 |
$111,821 |
| 2011-06-30 |
$112,114 |
| 2011-03-31 |
$108,150 |
| 2010-12-31 |
$102,908 |
| 2010-09-30 |
$98,247 |
| 2010-06-30 |
$92,300 |
| 2010-03-31 |
$93,441 |
| 2009-12-31 |
$94,682 |
| 2009-09-30 |
$91,558 |
| 2009-06-30 |
$87,438 |
| 2009-03-31 |
$86,100 |
| 2008-12-31 |
$84,912 |
| 2008-09-30 |
$87,724 |
| 2008-06-30 |
$88,113 |
| 2008-03-31 |
$85,995 |
| 2007-12-31 |
$80,954 |
| 2007-09-30 |
$78,665 |
| 2007-06-30 |
$74,683 |
| 2007-03-31 |
$73,066 |
| 2006-12-31 |
$70,556 |
| 2006-09-30 |
$61,238 |
| 2006-06-30 |
$60,990 |
| 2006-03-31 |
$62,133 |
| 2005-12-31 |
$58,864 |
| 2005-09-30 |
$56,574 |
| 2005-06-30 |
$54,553 |
| 2005-03-31 |
$54,446 |
| 2004-12-31 |
$53,317 |
| 2004-09-30 |
$52,089 |
| 2004-06-30 |
$50,171 |
| 2004-03-31 |
$48,868 |
| 2003-12-31 |
$48,263 |
| 2003-09-30 |
$46,659 |
| 2003-06-30 |
$45,653 |
| 2003-03-31 |
$41,994 |
| 2002-12-31 |
$40,556 |
| 2002-09-30 |
$38,663 |
| 2002-06-30 |
$38,351 |
| 2002-03-31 |
$38,296 |
| 2001-12-31 |
$38,488 |
| 2001-09-30 |
$37,053 |
| 2001-06-30 |
$36,101 |
| 2001-03-31 |
$31,875 |
| 2000-12-31 |
$34,245 |
| 2000-09-30 |
$30,784 |
| 2000-06-30 |
$30,305 |
| 2000-03-31 |
$29,963 |
| 1999-12-31 |
$29,163 |
| 1999-09-30 |
$28,108 |
| 1999-06-30 |
$27,126 |
| 1999-03-31 |
$26,746 |
| 1998-12-31 |
$26,211 |
| 1998-09-30 |
$23,333 |
| 1998-06-30 |
$22,308 |
| 1998-03-31 |
$21,915 |
| 1997-12-31 |
$21,453 |
| 1997-09-30 |
$21,677 |
| 1997-06-30 |
$21,005 |
| 1997-03-31 |
$20,620 |
| 1996-12-31 |
$20,010 |
| 1996-09-30 |
$19,910 |
| 1996-06-30 |
$19,305 |
| 1996-03-31 |
$18,940 |
| 1995-12-31 |
$17,873 |
| 1995-09-30 |
$17,689 |
| 1995-06-30 |
$17,389 |
| 1995-03-31 |
$16,639 |
| 1994-12-31 |
$15,668 |
| 1994-09-30 |
$14,833 |
| 1994-06-30 |
$13,442 |
| 1994-03-31 |
$12,826 |
| 1993-12-31 |
$12,242 |
| 1993-09-30 |
$12,401 |
| 1993-06-30 |
$12,213 |
| 1993-03-31 |
$11,962 |
| 1992-12-31 |
$11,884 |
| 1992-09-30 |
$11,811 |
| 1992-06-30 |
$11,239 |
| 1992-03-31 |
$10,461 |
| 1991-12-31 |
$10,513 |
| 1991-09-30 |
$9,853 |
| 1991-06-30 |
$9,429 |
| 1991-03-31 |
$9,294 |
| 1990-12-31 |
$9,506 |
| 1990-09-30 |
$9,549 |
| 1990-06-30 |
$9,171 |
| 1990-03-31 |
$8,640 |
| 1989-12-31 |
$7,919 |
| 1989-09-30 |
$7,608 |
| 1989-06-30 |
$7,604 |
| 1989-03-31 |
$7,364 |
| 1988-12-31 |
$7,119 |
| 1988-09-30 |
$6,900 |
| 1988-06-30 |
$7,087 |
| 1988-03-31 |
$6,970 |
| 1987-12-31 |
$6,546 |
| 1987-09-30 |
$6,720 |
| 1987-06-30 |
$6,504 |
| 1987-03-31 |
$6,245 |
| 1986-12-31 |
$5,877 |
| 1985-12-31 |
$5,095 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$450.090B |
$94.943B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
